Terms: = Pancreatic cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
115 results:
1. XQZ3, a Chlorella pyrenoidosa polysaccharide suppresses cancer progression by restraining mitochondrial bioenergetics via hsp90/AKT signaling pathway.
Sun L; Ji M; Liu Y; Zhang M; Zheng C; Wang P
Int J Biol Macromol; 2024 Apr; 264(Pt 2):130705. PubMed ID: 38458300
[TBL] [Abstract] [Full Text] [Related]
2. Prospects and challenges of noncoding-RNA-mediated inhibition of heat shock protein 90 for cancer therapy.
Mattoo S; Gupta A; Chauhan M; Agrawal A; Pore SK
Biochim Biophys Acta Gene Regul Mech; 2024 Mar; 1867(1):195006. PubMed ID: 38218528
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer.
Dong W; Zhao H; Xiao S; Zheng L; Fan T; Wang L; Zhang H; Hu Y; Yang J; Wang T; Xiao W
Front Immunol; 2023; 14():1263633. PubMed ID: 38149248
[TBL] [Abstract] [Full Text] [Related]
4. Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma.
Karatug Kacar A
Chem Biol Drug Des; 2024 Jan; 103(1):e14368. PubMed ID: 37802653
[TBL] [Abstract] [Full Text] [Related]
5. The therapeutic effects of exosomes the first time isolated from pancreatic islet-derived progenitor cells in the treatment of pancreatic cancer.
Hasoglu I; Karatug Kacar A
Protoplasma; 2024 Mar; 261(2):281-291. PubMed ID: 37798610
[TBL] [Abstract] [Full Text] [Related]
6. Promising targetable biomarkers in pancreatic neuroendocrine tumours.
Borghesani M; Gervaso L; Cella CA; Benini L; Ciardiello D; Algeri L; Ferrero A; Valenza C; Guidi L; Zampino MG; Spada F; Fazio N
Expert Rev Endocrinol Metab; 2023; 18(5):387-398. PubMed ID: 37743651
[TBL] [Abstract] [Full Text] [Related]
7. Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis.
Pavlakis E; Neumann M; Merle N; Wieboldt R; Wanzel M; Ponath V; Pogge von Strandmann E; Elmshäuser S; Stiewe T
J Exp Clin Cancer Res; 2023 Aug; 42(1):203. PubMed ID: 37563605
[TBL] [Abstract] [Full Text] [Related]
8. Resistance to Gemcitabine in pancreatic cancer Is Connected to Methylglyoxal Stress and Heat Shock Response.
Crake R; Gasmi I; Dehaye J; Lardinois F; Peiffer R; Maloujahmoum N; Agirman F; Koopmansch B; D'Haene N; Azurmendi Senar O; Arsenijevic T; Lambert F; Peulen O; Van Laethem JL; Bellahcène A
Cells; 2023 May; 12(10):. PubMed ID: 37408249
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with pancreatic cancer.
Zou T; Shi D; Wang W; Chen G; Zhang X; Tian Y; Gong P
Mediators Inflamm; 2023; 2023():5565054. PubMed ID: 37181810
[TBL] [Abstract] [Full Text] [Related]
10. Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles.
Zhang H; Zhang W; Hu B; Qin X; Yi T; Ye Y; Huang X; Song Y; Yang Z; Qian J; Zhang Y
J Nanobiotechnology; 2023 Apr; 21(1):117. PubMed ID: 37005668
[TBL] [Abstract] [Full Text] [Related]
11. Stress-Inducible SCAND Factors Suppress the Stress Response and Are Biomarkers for Enhanced Prognosis in cancers.
Sheta M; Yoshida K; Kanemoto H; Calderwood SK; Eguchi T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982267
[TBL] [Abstract] [Full Text] [Related]
12. New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in pancreatic cancer Cells and Their Potential for Theranostic Applications.
Balas M; Predoi D; Burtea C; Dinischiotu A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834718
[TBL] [Abstract] [Full Text] [Related]
13. Human γδ T cells induce CD8
Wang S; Li H; Chen T; Zhou H; Zhang W; Lin N; Yu X; Lou Y; Li B; Yinwang E; Wang Z; Wang K; Xue Y; Qu H; Lin P; Sun H; Teng W; Mou H; Chai X; Cai Z; Ye Z
Cancer Immunol Immunother; 2023 Jun; 72(6):1803-1821. PubMed ID: 36680568
[TBL] [Abstract] [Full Text] [Related]
14. Targeting proteostasis of the HEV replicase to combat infection in preclinical models.
Zhang F; Xu LD; Zhang Q; Wang A; Yu X; Liu S; Chen C; Wu S; Jin J; Lin A; Neculai D; Zhao B; Feng XH; Liang T; Xu P; Huang YW
J Hepatol; 2023 Apr; 78(4):704-716. PubMed ID: 36574921
[TBL] [Abstract] [Full Text] [Related]
15. Patient-Derived pancreatic cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and hsp90.
Wu HY; Trevino JG; Fang BL; Riner AN; Vudatha V; Zhang GH; Li YP
Cells; 2022 Sep; 11(17):. PubMed ID: 36078164
[TBL] [Abstract] [Full Text] [Related]
16. Heat Shock Proteins: Central Players in Oncological and Immuno-Oncological Tracks.
Youness RA; Gohar A; Kiriacos CJ; El-Shazly M
Adv Exp Med Biol; 2023; 1409():193-203. PubMed ID: 36038808
[TBL] [Abstract] [Full Text] [Related]
17. Mechanisms of pancreatic tumor suppression mediated by Xiang-lian pill: An integrated in silico exploration and experimental validation.
Jiao J; Cheng CS; Xu P; Yang P; Zhang K; Jing Y; Chen Z
J Ethnopharmacol; 2022 Nov; 298():115586. PubMed ID: 35931303
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of plasma LC3B
Chen YQ; Zheng L; Zhou J; Wang P; Wang L; Zhang Y; Man ZS; Chen YH; Gu F; Niu GP
Int Immunopharmacol; 2022 Jul; 108():108760. PubMed ID: 35398623
[TBL] [Abstract] [Full Text] [Related]
19. hsp90 inhibition acts synergistically with heat to induce a pro-immunogenic form of cell death in colon cancer cells.
Mouratidis PXE; Ter Haar G
Int J Hyperthermia; 2021; 38(1):1443-1456. PubMed ID: 34612127
[TBL] [Abstract] [Full Text] [Related]
20. Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis.
Ji F; Zhou M; Sun Z; Jiang Z; Zhu H; Xie Z; Ouyang X; Zhang L; Li L
Cancer Commun (Lond); 2021 Oct; 41(10):1007-1023. PubMed ID: 34196494
[TBL] [Abstract] [Full Text] [Related]
[Next]
